VitalDose

Bill & Melinda Gates Foundation Grant Fuels Celanese’s Development of Medical Device

by | Aug 25, 2022
The foundation's $626,000 grant will be used by Irving-based Celanese Corporation to produce a refillable contraceptive implant. The project's goal is to help women in developing countries who lack access to modern contraception options, and could benefit from more flexibility and control. To develop the device, Celanese will use its VitalDose drug delivery platform, an implantable device for controlled drug release that’s been used commercially in the U.S. and Europe.
MORE